Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.64 |
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | GAA | P10253 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29910198 | 0.86 | NPC1 (0.41) | RAB9ANPC1GAAMAPTL3MBTL1 | |
| SCHEMBL25275080 | 0.80 | TDP1 (0.59) | RAB9ANPC1GAAMAPTL3MBTL1 | |
| SCHEMBL11222030 | 0.79 | RAB9A (0.64) | RAB9ANPC1GAAMAPTL3MBTL1 | |
| SCHEMBL851498 | 0.78 | RAB9A (0.70) | RAB9ANPC1GAAMAPTL3MBTL1 | |
| SCHEMBL39057 | 0.78 | MAPT (1.00) | RAB9ANPC1GAAMAPTL3MBTL1 | |
| SCHEMBL1459772 | 0.78 | MAPT (1.00) | RAB9ANPC1GAAMAPTL3MBTL1 | |
| SCHEMBL11146268 | 0.78 | SMN1; SMN2 (0.44) | RAB9ANPC1GAAMAPTL3MBTL1 | |
| SCHEMBL14995939 | 0.77 | NQO1 (0.61) | RAB9ANPC1GAAMAPTKDM4E | |
| SCHEMBL28520010 | 0.77 | RAB9A (0.54) | RAB9ANPC1GAAMAPTL3MBTL1 | |
| SCHEMBL20041022 | 0.77 | HPGD (0.61) | RAB9ANPC1MAPTMAPK1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058720-A | Preparation and application of 7-alkyl camptothecine derivative containing hydroxylamine structure substitution | 杭州爱科瑞思生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| WO-2024143473-A1 | DECOMPOSITION INHIBITOR FOR TRANSITION METAL OXIDANTS | 株式会社トクヤマ | 2024-07-04 | — | — | WO | disclosed |
| US-9791399-B2 | Derivatization of carbon | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2017-10-17 | — | — | US | disclosed |
| US-20140332412-A1 | DERIVATIZATION OF CARBON | SCHLUMBERGER TECHNOLOGY COPORATION (US) | 2014-11-13 | — | — | US | disclosed |
| US-7968734-B2 | Organocatalysts and methods of use in chemical synthesis | STC.UNM (US) | 2011-06-28 | — | — | US | disclosed |
| CN-1807413-B | Carbazole sulfonamide derivative and its preparation method | INST MED BIOTECHNOLOGY CAMS | 2010-05-05 | — | — | CN | disclosed |
| US-20070244328-A1 | Organocatalysts and Methods of Use in Chemical Synthesis | STC.UNM (US) | 2007-10-18 | — | — | US | disclosed |
| CN-1807413-A | Carbazole sulfonamide derivative and its preparation method | MEDICINE AND BIOENGINEERING IN (CN) | 2006-07-26 | — | — | CN | disclosed |
| WO-2006007586-A1 | ORGANOCATALYSTS AND METHODS OF USE IN CHEMICAL SYNTHESIS | SCIENCE & TECHNOLOGY CORPORATION @ UNM (US) | 2006-01-19 | — | — | WO | disclosed |
| US-5059620-A | Antiarrhythmia agents | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1991-10-22 | — | — | US | disclosed |
| US-4923873-A | ANTIARRHYTHMIA AGENTS; SIDE EFFECT REDUCTION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-05-08 | — | — | US | disclosed |
| US-4755527-A | Aryl substituted aminomethyl benzene derivatives | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-07-05 | — | — | US | disclosed |
| US-4748184-A | Aryl substituted aminomethyl benzene derivatives having antiarrhythmic utility | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-05-31 | — | — | US | disclosed |
| US-4562201-A | ANTIARRHYTHMIA AGNETS | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1985-12-31 | — | — | US | disclosed |
| EP-0113778-A4 | ARYL SUBSTITUTED AMINOMETHYL BENZENE DERIVATIVES USEFUL AS ANTIARRHYTHMIC AGENTS. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1985-06-06 | — | — | EP | disclosed |
| EP-0113778-A1 | ARYL SUBSTITUTED AMINOMETHYL BENZENE DERIVATIVES USEFUL AS ANTIARRHYTHMIC AGENTS. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1984-07-25 | — | — | EP | disclosed |
| WO-1984000545-A1 | ARYL SUBSTITUTED AMINOMETHYL BENZENE DERIVATIVES USEFUL AS ANTIARRHYTHMIC AGENTS | AMERICAN HOSPITAL SUPPLY CORP (US) | 1984-02-16 | — | — | WO | disclosed |
| US-4224340-A | Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds | WILLIAM H. RORER, INC. (US) | 1980-09-23 | — | — | US | disclosed |
| US-4214003-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1980-07-22 | — | — | US | disclosed |
| US-4153722-A | ANTIINFLAMMATORY, A-PHENYL-N-PHENYLNITRONE | WILLIAM H. RORER, INC. (US) | 1979-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244328-A1 | Organocatalysts and Methods of Use in Chemical Synthesis | SCO2, CBR1, CBR3 | RAB9A 1447/4885NPC1 902/4885GAA 4167/4885 |
| US-20140332412-A1 | DERIVATIZATION OF CARBON | FTH1, CBR1, SDHB | RAB9A 4278/4885NPC1 4423/4885GAA 3656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.